Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rousseau

Showing results (91-100 of 524) with videos related to

Pageof 53
Sort By:
Pathologie-Biologie|November 1, 1992
[Taxol and ovarian adenocarcinomas]M Marty, J M Extra, S Culine, et al.
The American Journal of Cardiology|July 1, 1991
Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure StudyH Pouleur, M F Rousseau, C Oakley, et al.
European Heart Journal|April 1, 1990
Echocardiographic assessment of lack of beta 1-receptor down-regulation during prolonged therapy with xamoterolP Cheron, M Nannan, H Pouleur, et al.
Circulation|November 1, 1973
Hemodynamic determinants of maximal oxygen intake in patients with healed myocardial infarction: influence of physical trainingM F Rousseau, L A Brasseur, J M Detry
European Journal of Clinical Investigation|January 10, 2012
eNOS [Glu298Asp] polymorphism, erectile function and ocular pressure in type 2 diabetesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes & Metabolism|December 15, 2010
Statin therapy and cataract in type 2 diabetesM P Hermans, S A Ahn, M F Rousseau
AMIA ... Annual Symposium Proceedings. AMIA Symposium|May 2, 2023
Analyzing Impact of Socio-Economic Factors on COVID-19 Mortality Prediction Using SHAP ValueRedoan Rahman, Jooyeong Kang, Justin F Rousseau, et al.
Revue Medicale De Liege|January 9, 2014
[Hypovitaminosis D and burn injury]A F Rousseau, D Ledoux, P Damas, et al.
Peptides|January 1, 1986
Ectopic G-29 and G-37 glucagon secretion by hypercalcemic infantile renal tumorsM F Rousseau-Merck, F Mercier, D Bataille, et al.
Future Cardiology|June 7, 2017
Elevation of plasma oncostatin M in heart failureDamien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
Pageof 53

Showing results (91-100 of 524) with videos related to

Sort By:
Pageof 53
Pathologie-Biologie|November 1, 1992
[Taxol and ovarian adenocarcinomas]M Marty, J M Extra, S Culine, et al.
The American Journal of Cardiology|July 1, 1991
Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure StudyH Pouleur, M F Rousseau, C Oakley, et al.
European Heart Journal|April 1, 1990
Echocardiographic assessment of lack of beta 1-receptor down-regulation during prolonged therapy with xamoterolP Cheron, M Nannan, H Pouleur, et al.
Circulation|November 1, 1973
Hemodynamic determinants of maximal oxygen intake in patients with healed myocardial infarction: influence of physical trainingM F Rousseau, L A Brasseur, J M Detry
European Journal of Clinical Investigation|January 10, 2012
eNOS [Glu298Asp] polymorphism, erectile function and ocular pressure in type 2 diabetesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes & Metabolism|December 15, 2010
Statin therapy and cataract in type 2 diabetesM P Hermans, S A Ahn, M F Rousseau
AMIA ... Annual Symposium Proceedings. AMIA Symposium|May 2, 2023
Analyzing Impact of Socio-Economic Factors on COVID-19 Mortality Prediction Using SHAP ValueRedoan Rahman, Jooyeong Kang, Justin F Rousseau, et al.
Revue Medicale De Liege|January 9, 2014
[Hypovitaminosis D and burn injury]A F Rousseau, D Ledoux, P Damas, et al.
Peptides|January 1, 1986
Ectopic G-29 and G-37 glucagon secretion by hypercalcemic infantile renal tumorsM F Rousseau-Merck, F Mercier, D Bataille, et al.
Future Cardiology|June 7, 2017
Elevation of plasma oncostatin M in heart failureDamien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
Pageof 53